Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pan Tumor Rollover Study
Pan Tumor Rollover Study

NCT03899155

RecruitingPhase 2

Sponsor: Bristol-Myers Squibb

Conditions: Cancer

Interventions: Nivolumab, Ipilimumab, Cabozantinib, Trametinib, Relatlimab

Countries: United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria

* Signed Written Informed Consent.
* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.
* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.
* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.

Exclusion Criteria

* Participant is not eligible for study treatment per the Parent Study eligibility criteria.
* Participants not receiving clinical benefit as assessed by the Investigator.
* Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.
* Other protocol-defined Inclusion/Exclusion Criteria apply
Locations (399)
  • Huntsville, Alabama, United States
  • Tucson, Arizona, United States
  • Lynwood, California, United States
  • San Francisco, California, United States
  • San Francisco, California, United States
  • Aurora, Colorado, United States
  • New Haven, Connecticut, United States
  • Washington D.C., District of Columbia, United States
  • Ocala, Florida, United States
  • Orlando, Florida, United States
  • Tampa, Florida, United States
  • Chicago, Illinois, United States
  • Maywood, Illinois, United States
  • Park Ridge, Illinois, United States
  • Westwood, Kansas, United States
  • Wichita, Kansas, United States
  • Louisville, Kentucky, United States
  • Baltimore, Maryland, United States
  • Boston, Massachusetts, United States
  • Boston, Massachusetts, United States
  • Boston, Massachusetts, United States
  • Ann Arbor, Michigan, United States
  • Minneapolis, Minnesota, United States
  • St Louis, Missouri, United States
  • Omaha, Nebraska, United States
  • Lebanon, New Hampshire, United States
  • Albuquerque, New Mexico, United States
  • Buffalo, New York, United States
  • Mineola, New York, United States
  • New York, New York, United States
  • + 369 more on CT.gov